6PHO
Crystal structure of glucagon analog with selenomethionine substitutions at position 1 and 27 in space group I41 at 1.42 A resolution
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2018-05-17 |
Detector | RDI CMOS_8M |
Wavelength(s) | 0.97625 |
Spacegroup name | I 41 |
Unit cell lengths | 41.696, 41.696, 29.648 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 15.785 - 1.420 |
R-factor | 0.1613 |
Rwork | 0.160 |
R-free | 0.18900 |
Structure solution method | SAD |
RMSD bond length | 0.006 |
RMSD bond angle | 0.890 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.14_3260: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 29.480 | 1.710 |
High resolution limit [Å] | 1.420 | 1.420 |
Rmeas | 0.060 | 0.693 |
Rpim | 0.023 | 0.412 |
Number of reflections | 4708 | 1841 |
<I/σ(I)> | 20.1 | 1.5 |
Completeness [%] | 96.3 | 84 |
Redundancy | 6.1 | 2.7 |
CC(1/2) | 0.998 | 0.505 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.2 M tri-potassium citrate, 20% PEG3350 |